Brown spider venom toxins interact with cell surface and are endocytosed by rabbit endothelial cells

Toxicon

Volumn 56, Issue 4, 2010, Pages 535-543

  Nowatzki, Jenifer ^a   de Sene, Reginaldo Vieira ^a   Paludo, Katia Sabrina ^a,b   Veiga, Silvio Sanches ^a   Oliver, Constance ^c   Jamur, Maria Célia ^c   Nader, Helena Bonciani ^b   Trindade, Edvaldo S ^a   Franco, Célia Regina C ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Endocytosis; Endothelial cells; Loxosceles intermedia; Venom internalization

Indexed keywords

GLYCOCONJUGATE; SPIDER VENOM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; ENDOTHELIUM CELL; INTERNALIZATION; LYSOSOME; NONHUMAN; POISONOUS SPIDER; PRIORITY JOURNAL; RABBIT;

ANIMALIA; ARANEAE; LOXOSCELES; LOXOSCELES INTERMEDIA; ORYCTOLAGUS CUNICULUS;

EID: 77955013991     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.03.027     Document Type: Article

References (61)

1. 2 is a consequence of lysosomal rupture. Biochem. J. 2001, 356(Pt 2):549-555.
2. Baldwin A.L., Thurston G. Mechanics of endothelial cell architecture and vascular permeability. Crit. Rev. Biomed. Eng 2001, 29(2):247-278.
3. Barbaro K.C., Knysak I., Martins R., Hogan C., Winkel K. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas. Toxicon 2005, 45(4):489-499.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
5. Broeck D.V., Lagrou A.R., De Wolf M.J. Distinct role of clathrin-mediated endocytosis in the functional uptake of cholera toxin. Acta Biochim. Pol. 2007, 54(4):757-767.
6. Broekhuizen L.N., Mooij H.L., Kastelein J.J., Stroes E.S., Vink H., Nieuwdorp M. Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease. Curr. Opin. Lipidol. 2009, 20(1):57-62.
7. Brunk U.T., Svensson I. Oxidative stress, growth factor starvation and Fas activation may all cause apoptosis through lysosomal leak. Redox Rep. 1999, 4(1-2):3-11.
8. Buonassisi V., Venter J.C. Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proc. Natl. Acad. Sci. U.S.A. 1976, 73(5):1612-1616.
9. Chaim O.M., Sade Y.B., Da Silveira R.B., Toma L., Kalapothakis E., Chavez-Olortegui C., Mangili O.C., Gremski W., von Dietrich C.P., Nader H.B., Sanches Veiga S. Brown spider dermonecrotic toxin directly induces nephrotoxicity. Toxicol. Appl. Pharmacol. 2006, 211(1):64-77.
10. Chaves-Moreira D., Chaim O.M., Sade Y.B., Paludo K.S., Gremski L.H., Donatti L., de Moura J., Mangili O.C., Gremski W., da Silveira R.B., Senff-Ribeiro A., Veiga S.S. Identification of a direct hemolytic effect dependent on the catalytic activity induced by phospholipase-D (dermonecrotic toxin) from brown spider venom. J. Cell Biochem. 2009, 107(4):655-666.
11. Cirman T., Oresic K., Mazovec G.D., Turk V., Reed J.C., Myers R.M., Salvesen G.S., Turk B. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J. Biol. Chem. 2004, 279(5):3578-3587.
12. Cohen N., Sarafian D.A., Alon I., Gorelik O., Zaidenstein R., Simantow R., Blatt A., Litinsky I., Modai D., Golik A. Dermonecrotic loxoscelism in the Mediterranean region. J. Toxicol. Cut. Ocul. Toxicol. 1999, 18(1):75-83.
13. Cunha R.B., Barbaro K.C., Muramatsu D., Portaro F.C., Fontes W., De Sousa M.V. Purification and characterization of loxnecrogin, a dermonecrotic toxin from Loxosceles gaucho brown spider venom. J. Protein Chem. 2003, 22(2):135-146.
14. Da Silva P.H., Da Silveira R.B., Appel M.H., Mangili O.C., Gremski W., Veiga S.S. Brown spiders and loxoscelism. Toxicon 2004, 44(7):693-709.
15. da Silveira R.B., Chaim O.M., Mangili O.C., Gremski W., Dietrich C.P., Nader H.B., Veiga S.S. Hyaluronidases in Loxosceles intermedia (Brown spider) venom are endo-beta-N-acetyl-d-hexosaminidases hydrolases. Toxicon 2007, 49(6):758-768.
16. da Silveira R.B., Wille A.C., Chaim O.M., Appel M.H., Silva D.T., Franco C.R., Toma L., Mangili O.C., Gremski W., Dietrich C.P., Nader H.B., Veiga S.S. Identification, cloning, expression and functional characterization of an astacin-like metalloprotease toxin from Loxosceles intermedia (brown spider) venom. Biochem. J. 2007, 406(2):355-363.
17. da Silveira R.B., Pigozzo R.B., Chaim O.M., Appel M.H., Silva D.T., Dreyfuss J.L., Toma L., Dietrich C.P., Nader H.B., Veiga S.S., Gremski W. Two novel dermonecrotic toxins LiRecDT4 and LiRecDT5 from brown spider (Loxosceles intermedia) venom: from cloning to functional characterization. Biochimie 2007, 89(3):289-300.
18. de Souza A.L., Malaque C.M., Sztajnbok J., Romano C.C., Duarte A.J., Seguro A.C. Loxosceles venom-induced cytokine activation, hemolysis, and acute kidney injury. Toxicon 2008, 51(1):151-156.
19. Droga-Mazovec G., Bojic L., Petelin A., Ivanova S., Romih R., Repnik U., Salvesen G.S., Stoka V., Turk V., Turk B. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J. Biol. Chem. 2008, 283(27):19140-19150.
20. Feitosa L., Gremski W., Veiga S.S., Elias M.C., Graner E., Mangili O.C., Brentani R.R. Detection and characterization of metalloproteinases with gelatinolytic, fibronectinolytic and fibrinogenolytic activities in brown spider (Loxosceles intermedia) venom. Toxicon 1998, 36(7):1039-1051.
21. Feofanov A.V., Sharonov G.V., Astapova M.V., Rodionov D.I., Utkin Y.N., Arseniev A.S. Cancer cell injury by cytotoxins from cobra venom is mediated through lysosomal damage. Biochem. J. 2005, 390(Pt 1):11-18.
22. Futrell J.M. Loxoscelism. Am. J. Med. Sci. 1992, 304(4):261-267.
23. Hayashi M.A., Nascimento F.D., Kerkis A., Oliveira V., Oliveira E.B., Pereira A., Radis-Baptista G., Nader H.B., Yamane T., Kerkis I., Tersariol I.L. Cytotoxic effects of crotamine are mediated through lysosomal membrane permeabilization. Toxicon 2008, 52(3):508-517.
24. He J., Tohyama Y., Yamamoto K., Kobayashi M., Shi Y., Takano T., Noda C., Tohyama K., Yamamura H. Lysosome is a primary organelle in B cell receptor-mediated apoptosis: an indispensable role of Syk in lysosomal function. Genes Cells 2005, 10(1):23-35.
25. Henry C.B., DeFouw D.O. Differential lectin binding to microvascular endothelial glycoconjugates during normal angiogenesis in the chick chorioallantoic membrane. Microvasc. Res. 1995, 49(2):201-211.
26. Hogan C.J., Barbaro K.C., Winkel K. Loxoscelism: old obstacles, new directions. Ann. Emerg. Med. 2004, 44(6):608-624.
27. Ivanova S., Repnik U., Bojic L., Petelin A., Turk V., Turk B. Lysosomes in apoptosis. Methods Enzymol. 2008, 442:183-199.
28. Leist M., Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. 2001, 2(8):589-598.
29. Luciano M.N., Da Silva P.H., Chaim O.M., Dos Santos V.L., Franco C.R., Soares M.F., Zanata S.M., Mangili O.C., Gremski W., Veiga S.S. Experimental evidence for a direct cytotoxicity of Loxosceles intermedia (brown spider) venom in renal tissue. J. Histochem. Cytochem. 2004, 52(4):455-467.
30. Medina-Kauwe L.K. " Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?. Adv. Drug Deliv. Rev. 2007, 59(8):798-809.
31. Mehta D., Malik A.B. Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 2006, 86(1):279-367.
32. Nascimento F.D., Hayashi M.A., Kerkis A., Oliveira V., Oliveira E.B., Radis-Baptista G., Nader H.B., Yamane T., Tersariol I.L., Kerkis I. Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans. J. Biol. Chem. 2007, 282(29):21349-21360.
33. Nicholson G.M., Graudins A. Antivenoms for the treatment of spider envenomation. J. Toxicol. Tox. Rev. 2003, 22(1):35-59.
34. Ospedal K.Z., Appel M.H., Fillus Neto J., Mangili O.C., Sanches Veiga S., Gremski W. Histopathological findings in rabbits after experimental acute exposure to the Loxosceles intermedia (brown spider) venom. Int. J. Exp. Pathol. 2002, 83(6):287-294.
35. Padron D., Bizeau M.E., Hazel J.R. Is fluid-phase endocytosis conserved in hepatocytes of species acclimated and adapted to different temperatures?. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278(2):R529-R536.
36. Paludo K.S., Gremski L.H., Veiga S.S., Chaim O.M., Gremski W., De Freitas Buchi D., Nader H.B., Dietrich C.P., Franco C.R. The effect of brown spider venom on endothelial cell morphology and adhesive structures. Toxicon 2006, 47(8):844-853.
37. Paludo K.S., Biscaia S.M., Chaim O.M., Otuki M.F., Naliwaiko K., Dombrowski P.A., Franco C.R., Veiga S.S. Inflammatory events induced by brown spider venom and its recombinant dermonecrotic toxin: a pharmacological investigation. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2009, 149(3):323-333.
38. Patel K.D., Modur V., Zimmerman G.A., Prescott S.M., Mcintyre T.M. The necrotic venom of the brown recluse spider induces dysregulated endothelial cell-dependent neutrophil activation. Differential induction of GM-CSF, IL-8, and E-selectin expression. J. Clin. Invest. 1994, 94(2):631-642.
39. Plaut R.D., Carbonetti N.H. Retrograde transport of pertussis toxin in the mammalian cell. Cell. Microbiol. 2008, 10(5):1130-1139.
40. Reitsma S., Slaaf D.W., Vink H., Van Zandvoort M.A., Oude Egbrink M.G. The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch. 2007, 454(3):345-359.
41. Saraste A., Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. 2000, 45(3):528-537.
42. Senff-Ribeiro A., Henrique Da Silva P., Chaim O.M., Gremski L.H., Paludo K.S., Bertoni Da Silveira R., Gremski W., Mangili O.C., Veiga S.S. Biotechnological applications of brown spider (Loxosceles genus) venom toxins. Biotechnol. Adv. 2008, 26(3):210-218.
43. Sezerino U.M., Zannin M., Coelho L.K., Goncalves Junior J., Grando M., Mattosinho S.G., Cardoso J.L., Von Eickstedt V.R., Franca F.O., Barbaro K.C., Fan H.W. A clinical and epidemiological study of Loxosceles spider envenoming in Santa Catarina, Brazil. Trans. R. Soc. Trop. Med. Hyg. 1998, 92(5):546-548.
44. Sima A.V., Stancu C.S., Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res. 2009, 335(1):191-203.
45. Stewart W.W. Lucifer dyes-highly fluorescent dyes for biological tracing. Nature 1981, 292(5818):17-21.
46. Stoka V., Turk V., Turk B. Lysosomal cysteine cathepsins: signaling pathways in apoptosis. Biol. Chem. 2007, 388(6):555-560.
47. Swanson D.L., Vetter R.S. Loxoscelism. Clin. Dermato. 2006, 24(3):213-221.
48. Tambourgi D.V., De Sousa Da Silva M., Billington S.J., Goncalves De Andrade R.M., Magnoli F.C., Songer J.G., Van Den Berg C.W. Mechanism of induction of complement susceptibility of erythrocytes by spider and bacterial sphingomyelinases. Immunology 2002, 107(1):93-101.
49. Trindade E.S., Boucas R.I., Rocha H.A., Dominato J.A., Paredes-Gamero E.J., Franco C.R., Oliver C., Jamur M.C., Dietrich C.P., Nader H.B. Internalization and degradation of heparin is not required for stimulus of heparan sulfate proteoglycan synthesis. J. Cell. Physiol. 2008, 217(2):360-366.
50. Turk B., Stoka V., Rozman-Pungercar J., Cirman T., Droga-Mazovec G., Oresic K., Turk V. Apoptotic pathways: involvement of lysosomal proteases. Biol. Chem. 2002, 383(7-8):1035-1044.
51. van den Berg B.M., Vink H., Spaan J.A. The endothelial glycocalyx protects against myocardial edema. Circ. Res. 2003, 92(6):592-594.
52. Veiga S.S., Da Silveira R.B., Dreyfus J.L., Haoach J., Pereira A.M., Mangili O.C., Gremski W. Identification of high molecular weight serine-proteases in Loxosceles intermedia (brown spider) venom. Toxicon 2000, 38(6):825-839.
53. Veiga S.S., Feitosa L., Dos Santos V.L., De Souza G.A., Ribeiro A.S., Mangili O.C., Porcionatto M.A., Nader H.B., Dietrich C.P., Brentani R.R., Gremski W. Effect of brown spider venom on basement membrane structures. Histochem. J. 2000, 32(7):397-408.
54. Veiga S.S., Zanetti V.C., Franco C.R., Trindade E.S., Porcionatto M.A., Mangili O.C., Gremski W., Dietrich C.P., Nader H.B. In vivo and in vitro cytotoxicity of brown spider venom for blood vessel endothelial cells. Thromb. Res. 2001, 102(3):229-237.
55. Veiga S.S., Zanetti V.C., Braz A., Mangili O.C., Gremski W. Extracellular matrix molecules as targets for brown spider venom toxins. Braz. J. Med. Biol. Res. 2001, 34(7):843-850.
56. Vetter R.S., Visscher P.K. Bites and stings of medically important venomous arthropods. Int. J. Dermatol. 1998, 37(7):481-496.
57. Wang C.H., Liu J.H., Lee S.C., Hsiao C.D., Wu W.G. Glycosphingolipid-facilitated membrane insertion and internalization of cobra cardiotoxin. The sulfatide cardiotoxin complex structure in a membrane-like environment suggests a lipid-dependent cell-penetrating mechanism for membrane binding polypeptides. J. Biol. Chem. 2006, 281(1):656-667.
58. Weinbaum S., Tarbell J.M., Damiano E.R. The structure and function of the endothelial glycocalyx layer. Annu. Rev. Biomed. Eng. 2007, 9:121-167.
59. Wolkers W.F., Looper S.A., Fontanilla R.A., Tsvetkova N.M., Tablin F., Crowe J.H. Temperature dependence of fluid phase endocytosis coincides with membrane properties of pig platelets. Biochim. Biophys. Acta 2003, 1612(2):154-163.
60. Young A.R., Pincus S.J. Comparison of enzymatic activity from three species of necrotising arachnids in Australia: Loxosceles rufescens, Badumna insignis and Lampona cylindrata. Toxicon 2001, 39(2-3):391-400.
61. Zanetti V.C., Da Silveira R.B., Dreyfuss J.L., Haoach J., Mangili O.C., Veiga S.S., Gremski W. Morphological and biochemical evidence of blood vessel damage and fibrinogenolysis triggered by brown spider venom. Blood Coagul. Fibrinolysis 2002, 13(2):135-148.